Evidence map›Paper›PMID 41526190›Full record

ArticleGenome research2026

Chromosome engineering to correct a complex rearrangement on Chromosome 8 reveals the effects of 8p syndrome on gene expression and neural differentiation.

Sophia N Lee, Erin C Banda, Lu Qiao, Sarah L Thompson, Karan Singh, Ryan A Hagenson, Teresa Davoli, Stefan F Pinter, Jason M Sheltzer

Abstract read
In one paragraph

Article in Genome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Sophia N LeeYale University School of Medicine, New Haven, Connecticut 06510, USA.
Erin C Banda *Department of Genetics and Genome Sciences, UCONN Health, University of Connecticut, Farmington, Connecticut 06030, USA.
Lu Qiao *Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Sarah L ThompsonYale University School of Medicine, New Haven, Connecticut 06510, USA.
Karan SinghInstitute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, New York 10016, USA.
Ryan A HagensonYale University School of Medicine, New Haven, Connecticut 06510, USA.
Teresa DavoliInstitute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, New York 10016, USA.
Stefan F PinterDepartment of Genetics and Genome Sciences, UCONN Health, University of Connecticut, Farmington, Connecticut 06030, USA; spinter@uchc.edu jason.sheltzer@yale.edu.ORCID 0000-0003-4750-1403
Jason M SheltzerYale University School of Medicine, New Haven, Connecticut 06510, USA; spinter@uchc.edu jason.sheltzer@yale.edu.

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI Eric P. Winer · 1985 to 2026
$85.0M
Why do Down Syndrome patients have high risk of Hirschsprung disease?R01DK135089 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI, Sumantra Chatterjee · 2022 to 2026
$4.2M
Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1R37CA248631 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Teresa Davoli · 2021 to 2026
$2.9M
Genomic and functional approaches to characterize Chr1q gains in cancerR01CA276666 · NCI · YALE UNIVERSITY · PI Jason Sheltzer, Ruping Sun · 2023 to 2026
$2.4M
Discovering the mechanisms-of-action of mistargeted anti-cancer agentsR01CA237652 · NCI · YALE UNIVERSITY · PI SHELTZER, JASON · 2020 to 2024
$1.6M
Developmental constraints shaping human sex chromosomes and escape from X inactivationR35GM153326 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Stefan F. Pinter · 2024 to 2026
$1.3M
Flow cytometer for high-parameter analysesS10OD026996 · OD · YALE UNIVERSITY · PI HABERMAN, ANN M · 2019 to 2019
$596k
DOD W81XWH-20-1-068NCI NIH HHS P30 CA016359NCI NIH HHS R01 CA237652NCI NIH HHS R01 CA276666NCI NIH HHS R37 CA248631NIDDK NIH HHS R01 DK135089NIGMS NIH HHS R35 GM153326NIH HHS S10 OD026996
6 · The paper itself

Abstract

Chromosomal rearrangements on the short arm of Chromosome 8 cause 8p syndrome, a rare developmental disorder characterized by neurodevelopmental delays, epilepsy, and cardiac abnormalities. Although significant progress has been made in managing the symptoms of 8p syndrome and other conditions caused by large-scale chromosomal aneuploidies, no therapeutic approach has yet been demonstrated to target the underlying disease-causing chromosome. Here, we establish a two-step approach to eliminate the abnormal copy of Chromosome 8 and restore euploidy in cells derived from an individual with a complex rearrangement of Chromosome 8p. Transcriptomic analysis revealed 361 differentially expressed genes between the proband and the euploid revertant, highlighting genes both within and outside the 8p region that may contribute to 8p syndrome pathology. Furthermore, we demonstrate that the proband exhibits a significant defect in neural differentiation that could be partially rescued by treatment with small-molecule inhibitors of cell death. Our work demonstrates the feasibility of using chromosome engineering to correct complex aneuploidies in vitro and establishes a platform to further dissect the pathophysiology of 8p syndrome and other conditions caused by chromosomal rearrangements.

Indexed as

Chromosomes, Human, Pair 8Genetic EngineeringAneuploidyCell DifferentiationChromosome AberrationsHumansNeurons

Identifiers

PMID41526190
PMCPMC12951946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.